000 | 01795 a2200529 4500 | ||
---|---|---|---|
005 | 20250516190555.0 | ||
264 | 0 | _c20140902 | |
008 | 201409s 0 0 eng d | ||
022 | _a1471-2407 | ||
024 | 7 |
_a10.1186/1471-2407-14-2 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHasan, Raghibul | |
245 | 0 | 0 |
_aMitogen activated protein kinase kinase kinase 3 (MAP3K3/MEKK3) overexpression is an early event in esophageal tumorigenesis and is a predictor of poor disease prognosis. _h[electronic resource] |
260 |
_bBMC cancer _cJan 2014 |
||
300 |
_a2 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aBiomarkers, Tumor _xanalysis |
650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xenzymology |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aChi-Square Distribution |
650 | 0 | 4 | _aDisease-Free Survival |
650 | 0 | 4 |
_aEsophageal Neoplasms _xenzymology |
650 | 0 | 4 | _aEsophageal Squamous Cell Carcinoma |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 | _aKaplan-Meier Estimate |
650 | 0 | 4 | _aLymphatic Metastasis |
650 | 0 | 4 |
_aMAP Kinase Kinase Kinase 3 _xanalysis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aMultivariate Analysis |
650 | 0 | 4 | _aOdds Ratio |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aUp-Regulation |
700 | 1 | _aSharma, Rinu | |
700 | 1 | _aSaraya, Anoop | |
700 | 1 | _aChattopadhyay, Tushar K | |
700 | 1 | _aDattaGupta, Siddartha | |
700 | 1 | _aWalfish, Paul G | |
700 | 1 | _aChauhan, Shyam S | |
700 | 1 | _aRalhan, Ranju | |
773 | 0 |
_tBMC cancer _gvol. 14 _gp. 2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1471-2407-14-2 _zAvailable from publisher's website |
999 |
_c23410343 _d23410343 |